Ligand validation:8GN1

PL9: 2,3-DIMETHYL-5-(3,7,11,15,19,23,27,31,35-NONAMETHYL-2,6,10,14,18,22,26,30,34-HEXATRIACONTANONAENYL-2,5-CYCLOHEXADIENE-1,4-DIONE-2,3-DIMETHYL-5-SOLANESYL-1,4-BENZOQUINONE

PL9 is a Ligand Of Interest in 8GN1 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8GN1_PL9_D_407	71%	40%	0.129	0.95	0.72	1.58	2	15	0	0	100%	1
8GN1_PL9_d_407	48%	40%	0.181	0.924	0.74	1.58	1	15	0	0	100%	1
8GN1_PL9_x_801	27%	43%	0.184	0.881	0.4	1.77	-	15	0	0	71%	0.7091
8GN1_PL9_A_417	2%	43%	0.42	0.73	0.52	1.67	-	9	0	0	71%	0.7091
5WS6_PL9_D_405	97%	38%	0.055	0.967	0.67	1.74	2	20	0	0	100%	1
5GTI_PL9_d_405	96%	36%	0.053	0.962	0.64	1.86	2	22	0	0	100%	1
5V2C_PL9_d_407	96%	34%	0.069	0.978	1.27	1.32	8	10	0	0	100%	1
5B66_PL9_D_412	93%	35%	0.077	0.97	1.06	1.51	3	12	0	0	100%	1
5ZZN_PL9_D_407	92%	34%	0.081	0.973	1.11	1.47	6	7	0	0	100%	1
8F4C_PL9_D_407	90%	33%	0.083	0.964	0.91	1.71	3	14	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.